Expired contract

NHS Framework Agreement for the supply of Direct Oral Anticoagulants (DOACs) for the NHS in England

Details

Buyer: NHS England
Supplier(s): Bristol-Myers Squibb Pharmaceuticals Ltd, Bayer Ltd, Daiichi Sankyo UK Ltd
Value: £3,185,000,000
Duration: 2 years
Topic: Pharmaceutical products
Published: 25 November 2021
Source: uk:contracts_finder

Tender description

NHS Framework Agreement for the supply of Direct Oral Anticoagulants (DOACs) for the NHS in England. Also known as Novel Oral Anticoagulants (NOACs). Period of Framework: 01/01/2022 - 31/03/2024 with an option to extend (at the Authority's discretion) for a further period (or periods) up to a total of 12 months (i.e. total possible framework duration of 39 months)

Timeline

Completed: Award published25 November 2021
Current notice
Completed: Award date1 January 2022
Completed: Contract expiry date31 March 2024

About the buyer

NHS England runs the NHS in England, and buys as a central healthcare organisation with its own team of procurement professionals. Much of this procurement flows through framework agreements and the Crown Commercial Service. Seven regional teams support the commissioning of healthcare services across the country. The central commercial function that develops procurement strategy for the whole NHS sits here.

Clinical services are commissioned directly or through the Provider Selection Regime.

Over the past 5 years, most of NHS England's contract awards have been in education and training, health and social work, and IT services.

Decision makers

Connect with the people behind this procurement.

Job title	Phone number	Work email
Head of Procurement	+44 •••• ••••••	••••••••@nhs-england.gov
Commercial Director	+44 •••• ••••••	••••••••@nhs-england.gov
Procurement Manager	+44 •••• ••••••	••••••••@nhs-england.gov
Category Lead	+44 •••• ••••••	••••••••@nhs-england.gov
Senior Buyer	+44 •••• ••••••	••••••••@nhs-england.gov
Contracts Manager	+44 •••• ••••••	••••••••@nhs-england.gov